Join the session using the link: Zoom Link

Objectives

After participating in this educational activity, attendees should be able to:
1| Summarize the OHRP and FDA requirements for human subjects research training.

2| Distinguish how CITI training achieves part of the federal requirements.

3| Describe the terms therapeutic misconception and clinical equipoise as they relate to ethical conduct of research.

Presenter(s): 

Susan Garrow-Sloan, RN, CCRP
Education and Quality Assurance (EQA) Specialist
Baystate Health

Peter A. DePergola II, PhD, ThDc, MTS, HEC-C
Chief Ethics Officer & Senior Director, Clinical and Organizational Ethics
Chief, Ethics Consultation Service & Chair, Ethics Advisory Committee
Director, Clinical and Organizational Ethics Postgraduate Programs
Adjunct Associate Professor of Medicine, UMass Chan Medical School - Baystate
Office of Clinical and Organizational Ethics, Division of Healthcare Quality
Baystate Health
 
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Susan Garrow-Sloan, RN,Speaker/AuthorNo relevant relationships with ineligible companies to disclose 
Peter A. DePergola II, PhD, ThDc, MTS, HEC-CSpeaker/Author
No relevant relationships with ineligible companies to disclose
 

 

Session date: 
07/16/2025 - 2:00pm to 3:00pm EDT
Location: 
MA
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Risk Management
  • 1.00 IPCE Credit Hour(s)
Please login or register to take this course.